Baxter International is selling its biopharma solutions business to private equity firms. The transaction is part of a broader trend in which life science firms are spinning out or selling operations in order to hone the focus of the remaining business on certain areas.
Outset Medical just raised $60 million - and possibly more - to build out its at-home dialysis machine for patients with kidney failure.
See how Quantum Health is providing the steps to help their members tackle the cost of specialty medications and other drugs.
John L. Miclot has been appointed CEO of Tengion (NASDAQ:TNGN), a regenerative medicine business in East Norriton, Pennsylvania, as it pursues strategic partnership discussions. Miclot fills a vacancy left by Steven A. Nichtberger who resigned in June. David I Scheer, chairman of Tengion’s board, had taken a more active role in the company until a […]
Tornier Inc. is planning to test the choppy waters of Wall Street with an estimated $205 million initial public offering, according to documents filed with the Securities and Exchange Commission. The orthopedics firm in Edina, Minn., which specializes in devices to treat injuries to extremities and small bones, is the third local medical device company […]
Given Wall Street’s turmoil of late, it’s not too surprising that buyers would search for bargains, especially struggling medical device companies with promising technology and awful balance sheets. Case in point: Medtronic Inc.’s (NYSE: MDT) $370 million purchase of ATS Medical Inc. in Plymouth, Minn. But ev3 Inc. (NASDAQ: EVVV) and Virtual Radiological Corp. (NASDAQ: […]
Another one bites the dust. If Minnesota is to build a vibrant biotechnology industry, as I wrote earlier today, it will need all of the homegrown talent and technology it can muster. Unfortunately, what little we did have went out the door today when Landec Corp., based in Menlo Park, Calif., said it will pay […]
Help shape the future of healthcare benefits by sharing your insights.
The deal marks the first investment out of NEP's $1.2 billion Fund IX, which closed September 2008. What makes the deal even more interesting is NEP's partnership with Split Rock, a prominent venture capital firm based in Eden Prairie.